Business Wire

CT-XEROX

18.11.2020 21:07:11 CET | Business Wire | Press release

Share
Xerox Reveals Suite of Production Print Innovations to Address Industry Demand

Xerox (NYSE: XRX) announced a suite of production print innovations including new presses, technology enhancements for existing printers as well as artificial intelligence and automation features that aid speed and productivity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118006025/en/

At a virtual event attended by partners and clients around the world, Xerox unveiled the following innovations:

  • A Color Accelerator module for Baltoro, expanding inkjet applications and adding ink-saving automation
  • Addition of fluorescent pink to the Iridesse Production Press, enhancing its metallics, white and clear color palette
  • Three new printers capable of higher volumes, more media and extended color options in the VersaLink and Versant family
  • Two Xerox Nuvera print speed upgrades that best competition
  • AI-enabled media manager software that enables high-quality images with minimal set-up and staff time
  • Automated workflow updates to seamlessly print embellishments with FreeFlow Core 6.0

As the leader in the production color market, Xerox is committed to helping customers expand their business, enhance productivity with new technology and protect their existing investments with new tools and features.

Digital print enhancements increase profitability, delivering higher margins and allowing print customers to expand into new areas. According to Keypoint Intelligence, digital print enhancement is expected to generate $25 billion a year and can increase a printers’ profit by 50 to 400 percent. By making it easier, customizable and faster to produce these pages, Xerox technology provides multiple entry options for customers to expand their business and increase profit.

“Print enhancement is the fastest-growing segment in print and Xerox offers the broadest set of solutions to help clients expand their business here,” said Tracey Koziol, senior vice president of Global Offerings, Xerox. “The new technology and features we are launching expand the capabilities and profit potential of existing devices while introducing new presses that respond to demand for higher volume and extended media and color palettes. There’s a reason Xerox remains top in the production print market.”

Xerox Color Accelerator for Baltoro
The Xerox Baltoro™ High Fusion Inkjet Press platform, No. 1 in the B3 cut-sheet inkjet market, now has a field-upgradable module that expands its range. The Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press enables increased print quality, expanded media options and automation to make inkjet printing viable for lucrative applications such as direct mail, postcards and catalogs. With intelligent automation, Baltoro uses 50% less ink than competitor presses to purge inkjet heads, increasing uptime and productivity while delivering consistent, reliable quality.

Introduced last year, Baltoro is redefining the inkjet market. At a fraction of the size, weight and power consumption of competitor presses, Baltoro offers a lower total cost of ownership (TCO) while being the only scalable, customizable platform in its class.

Fluorescent Pink for Iridesse
Xerox has the broadest color capability and Beyond CMYK offerings across any portfolio. No one offers the range of colors, embellishments, mixed metallics, extended gamut, media options and single-pass digital enhancement technology as Xerox.

The Xerox Iridesse® Production Press is adding fluorescent pink specialty dry ink option to its existing Beyond CMYK palette of gold, silver, white and clear. These embellishments allow print providers to differentiate and offer their clients eye-popping designs and enhancements.

New VersaLink Graphic Arts Printer
The newest addition to our VersaLink family is the Xerox VersaLink® C8000W , the most affordable entry point into the embellishment market. Using white toner as a base on dark and colored stocks, its cyan, magenta and yellow toners make images pop for applications such as menus, envelopes, window clings, decals and labels. A small footprint device, the C8000W offers clarity and quality that stands out over the typical four-color print.

Two New Versants
Xerox is expanding its Versant family of presses with two new machines that support wider media options and add automation features that reduce staffing needs and set-up time.

The Xerox Versant® 280 Press , a mid-production press, provides added value with thicker stock media options (400 GSM) for applications such as business cards. With the All Stocks at Rated Speed (ASRS) option, the Versant 280 is faster than any competitor in printing heavy stocks. Customers can print a million specialty colors using an Adaptive CMYK+ kit that leverages white, gold, silver, clear and fluorescents, unique to Xerox in this class of products.

The Xerox Versant 4100 Press , handles higher volumes and heavier production loads than the Versant 280, bringing more jobs in-house by reducing set-up time and printing on more media types than any competitor press. The 4100 also handles thicker paper stocks, up to 400 GSM. Automated stock management saves time and reduces human error.

Faster Xerox Nuveras
The Xerox Nuvera® family is built for high production environments with our customers making more than 35 billion prints last year. The Xerox Nuvera 157 MX Production System and Xerox Nuvera MX Perfecting Production System monochrome production presses have upgraded the magnetic ink character recognition (MICR) print speeds to exceed any competitive press. MICR, the line of numbers that allows certain computers to read and process information, is key for processing bank, payroll and government checks with tested and trusted Xerox Nuvera security.

Technology-Driven Efficiencies
AI-enabled media manager software. PredictPrint Media Manager Software is included with the new Versant 4100 and can be added to Iridesse. By using artificial intelligence, the software automatically identifies the media being used and provides the correct press settings. Users simply scan a barcode, place the paper in a tray, and use the set-up wizard to walk through optimizing the system for that application.

FreeFlow® Core 6.0 automates the process of preparing a file to print and now includes the application of Beyond CMYK enhancements. FreeFlow Core uses pre-built workflows to seamlessly apply embellishments such as gold, silver, white, clear and fluorescents without changing the source file.

“These new products and features represent the sweet spot of technology, where end-to-end solutions support our customers need to differentiate and expand their businesses in any economic environment,” said Marybeth Gilbert, vice president and general manager, Production Business, Xerox. “Our customers know they can count on Xerox innovation in response to their business needs.”

Availability:

  • Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press - Current Baltoro customers will be able to order Color Accelerator beginning in 2021. New Baltoro customers will be able to place orders for Color Accelerator starting December 15 with installs expected to begin in Q1 2021.
  • The VersaLink C8000W is available immediately worldwide.
  • The Xerox Nuvera 157 MX Production System and Xerox Nuvera 314 MX Perfecting Production System - order taking and availability December 1, 2020.
  • The Xerox Versant 280 is available now based upon channel and geography.
  • The Xerox Versant 4100 with PredictPrint Media Manager Software is available now based upon channel and geography.
  • Iridesse pink specialty dry ink option and the PredictPrint Media Manager Software option are available for order taking December 1, 2020 and availability beginning March 1, 2021.
  • The XLS Automatic Feeding Kit option for Iridesse is available immediately worldwide.

About Xerox
Xerox Holdings Corporation (NYSE: XRX) makes every day work better.
We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. Learn how that innovation continues at xerox.com .

Note: To receive RSS news feeds, visit https://www.news.xerox.com . For open commentary, industry perspectives and views, visit http://twitter.com/xerox , http://www.facebook.com/XeroxCorp , https://www.instagram.com/xerox/ , http://www.linkedin.com/company/xerox , http://www.youtube.com/XeroxCorp .

Xerox® , Baltoro™, FreeFlow® , Iridesse® , VersaLink® , Versant® and Xerox Nuvera® are trademarks of Xerox in the United States and/or other countries.

Link:

ClickThru

Social Media:

https://www.facebook.com/XeroxCorp/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye